Trademark Overview
On Thursday, November 7, 2024, a trademark application was filed for CARNEGIE PHARMA with the United States Patent and Trademark Office. The USPTO has given the CARNEGIE PHARMA trademark a serial number of 98841106. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 7, 2024. This trademark is owned by Carnegie Pharmaceuticals LLC. The CARNEGIE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:
Dietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical products for the prevention and treatment of cancer; Thyroid and para-thyroid hormone preparations; Vitamin and mineral preparations for medical use
